pharma-company /Medicinal products /Active ingredients

Rx · PZN 15631203, 20083933

OGIVRI 420 mg powder for a concentrate for preparation of a solution for infusion

German trade nameOGIVRI 420 mg Pulver für einer Konzentrat zur Herstellung einer Infusionslösung

Active ingredientTrastuzumab

Only sporadically available

1.3

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €1,762

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for OGIVRI 420 mg powder for a concentrate for preparation of a solution for infusion.

Review purchasing terms

OGIVRI 420 mg powder for a concentrate for preparation of a solution for infusion contains the active ingredient Trastuzumab. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 1.3 out of 10. The best-available pack was only sporadically available.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
156312031.31.3~ €1,762
200839330.00.0~ €1,762

OGIVRI 420 mg powder for a concentrate for preparation of a solution for infusion was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.